Medacta Group reported preliminary, unaudited revenue of 683.8 million euros for full-year 2025, a year-over-year increase of 18.5% in constant currency and 15.8% in euros.
The orthopedic device company said growth was driven by strong performance across all business lines and geographic regions, with Asia Pacific revenue rising 23% and North America increasing 19%. Latin America, the smallest market, grew 42.2%, according to a Feb. 3 news release shared with Becker’s.
By product line, knee revenue rose 20.7% in constant currency to 284.1 million euros, hip grew 11.9% to 270.5 million euros, extremities increased 46.2% to 72.1 million euros and spine rose 12.2% to 57 million euros.
The March 2025 acquisition of Parcus Medical contributed about 1.5% to annual revenue. Medacta also added 258 new jobs during the year and is close to completing a new fully automated warehouse in Italy to support its supply chain in Europe, the Middle East and Africa.
The company will release audited 2025 financial results March 13.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
